Do boutique cohort studies have a role in diabetes epidemiology?

Tue 12 September 2023

MRC Epidemiology Unit

All are invited to the MRC Epidemiology Seminar:

Do boutique cohort studies have a role in diabetes epidemiology?

Professor Timothy Davis, University of Western Australia

This hybrid seminar will be held in the MRC Epidemiology Unit meeting rooms 1 and 2, Level 3, Wellcome-MRC Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge, CB2 0QQ, and online.

Register to attend in-person at: https://www.eventbrite.com/e/mrc-seminar-series-prof-timothy-davis-university-of-western-australia-tickets-699000909537

Register to join this seminar online at: https://mrc-epid.zoom.us/meeting/register/tJIqd-mgrDsqHNzc3ecg-i5KuDXigKLrHQjV#/registration

After registering, you will receive a confirmation email containing information about joining the meeting.

About this talk
In the age of big administrative datasets, including those from intervention trials, there is still an argument for more detailed patient-level data from community-based cohorts. One such cohort is that from the Fremantle Diabetes Study which was started 30 years ago and which has generated a wealth of data relating to diabetes management, complications and cost in a representative urban Australian setting.

About Professor Davis
Timothy Davis is Professor of Medicine and a Consultant Endocrinologist and General Physician in Perth, Western Australia (WA). He graduated in medicine from the University of WA, obtained a DPhil from Oxford University, and completed his physician training in the UK before taking up a postdoctoral position in Oxford University’s Tropical Research Unit in Bangkok. From there he took up his current academic and clinical appointments in Perth. He is an International Advisor to the Royal College of Physicians in London and a Fellow of the Australian Academy of Health and Medical Sciences.